Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: Acute lymphoblastic leukemia is the most common blood cancer in pediatric patients. Despite the enormous progress in ALL treatment, which is reflected by a high 5-year overall survival rate that reaches up to 96% in the most recent studies, there are still patients that cannot be sav...

Descripción completa

Detalles Bibliográficos
Autores principales: Malczewska, Marta, Kośmider, Kamil, Bednarz, Kinga, Ostapińska, Katarzyna, Lejman, Monika, Zawitkowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032060/
https://www.ncbi.nlm.nih.gov/pubmed/35454927
http://dx.doi.org/10.3390/cancers14082021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032060/
https://www.ncbi.nlm.nih.gov/pubmed/35454927
http://dx.doi.org/10.3390/cancers14082021

Ejemplares similares